Related Experiment Video
Updated: Aug 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Stroke: a vascular pathology with inadequate management
1Department of Neurology, University of Carver College of Medicine, Iowa City, Iowa, USA. harold-adams@uiowa.edu
Insights
Stroke remains a major global health challenge, necessitating advanced prevention and treatment strategies beyond current therapies. New approaches targeting vascular health and plaque stabilization are crucial for reducing stroke incidence and impact.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Stroke is a primary cause of global mortality and disability, with increasing prevalence projected.
- Current stroke care, including thrombolytic therapy, shows success but has limitations, such as a narrow therapeutic window.
- Despite advances in prevention and treatment, further measures are essential to mitigate the neurological consequences and reduce the global burden of stroke.
Purpose of the Study:
- To review current and emerging strategies for stroke prevention and treatment.
- To highlight the need for novel approaches to limit neurological damage and reduce stroke risk.
- To explore promising interventions for stabilizing vascular endothelium and preventing atherosclerotic plaque rupture.
Main Methods:
- Review of existing literature on stroke treatment and prevention.
- Analysis of the efficacy and limitations of current therapeutic interventions, including thrombolytic therapy, surgery, and antithrombotic medications.
- Evaluation of novel preventative strategies, such as endothelial stabilization and plaque stabilization.
Main Results:
- Thrombolytic therapy has improved stroke outcomes but is constrained by a short therapeutic window.
- Surgical interventions and antithrombotic medications effectively reduce stroke and recurrent stroke likelihood.
- Emerging strategies like vascular endothelium stabilization and atherosclerotic plaque stabilization show significant promise for further risk reduction.
Conclusions:
- Integrated approaches combining existing treatments with novel strategies are necessary to combat the growing burden of stroke.
- Medications such as cholesterol-lowering and antihypertensive agents (e.g., angiotensin-converting enzyme inhibitors) are vital for stroke prevention.
- Future stroke management should incorporate antithrombotic agents, surgical interventions, and novel therapies targeting vascular health for comprehensive risk reduction.
Abstract:
Stroke is a leading cause of death and disability in the world, and the worldwide burden from stroke will increase further during the 21st century. Major advances in the treatment and prevention of stroke have occurred but additional measures are needed. Much of the modern care of stroke mimics the modern treatment of heart disease, in part because of the success of thrombolytic therapy in improving outcomes. Nevertheless, the impact of thrombolytic therapy is limited because of the short therapeutic window. Additional measures are needed to limit the neurological consequences of stroke. Prevention remains a critical component of the management of patients with cerebrovascular disease. Although surgical therapies and antithrombotic medications (antiplatelet agents and anticoagulants) are effective in lessening the likelihood of stroke or recurrent stroke, new strategies are needed to lower the risk further. Measures aimed at stabilizing the vascular endothelium or preventing fracture of atherosclerotic plaques show great promise. Medications including cholesterol-lowering agents and antihypertensive medications, such as the angiotensin-converting enzyme inhibitors, appear effective in stroke prevention. These agents could be combined with antithrombotic agents and surgical interventions to lessen the risk of stroke.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

